Summary A human bladder carcinoma cell line was irradiated at high and low dose rates and exposed to camptothecin and VP16, inhibitors of topoisomerase I and topoisomerase II respectively. Although camptothecin substantially modifed the cytotoxic effects of high dose rate irradiation, abolished low dose rate sparing and inhibited the repair of sublethal and potentially lethal damage, VP16 had no effect on the survival curves even at highly cytotoxic doses. Thus, it is argued that there is a role for topoisomerase I but not topoisomerase II in the repair of DNA damage induced by ionising radiation.
DNA topoisomerases are proposed as regulators of the superhelical configuration of cellular DNA. By passing DNA strands through one another (single-stranded in the case of topoisomerase I, double-stranded in that of topoisomerase II) these enzymes are able to relax supercoils in the chromatin (Wang, 1985) . Topoisomerase II has been shown to be located at the base of chromatin loops (Wang, 1985) and to be regulated in its expression through the cell cycle (Heck et al., 1988) . It has been proposed as playing an important role in the control of changes in structure of the DNA throughout the cycle; condensation and separation of chromatids during mitosis (Earnshaw et al., 1985; Holm et al., 1985; Uemera et al., 1987) , decondensation during GI, replication during S (Mattern & Painter, 1979; Mattern & Scudiero, 1981; Nelson et al., 1986) possibly involving the separation of recombinant structures, subsequent recondensation during G2 and also the unwinding of specific regions for gene expression (Mattern & Scudiero, 1981; Nishio & Uyeki, 1982; Rowe et al., 1986) . Topoisomerase I has been implicated in replication (Yanagida & Wang, 1987) and transcription (Garg et al., 1987) . The hypothesis has also been advanced that topoisomerase activity might have a role to play in the repair of DNA damage in that localised unwinding of the chromatin may be necessary to render lesions readily accessible to bulky repair complexes. Recently Downes & Johnson (1988) have speculated that the association of topoisomerase I with transcriptionally active areas of the DNA (Fleischmann et al., 1984) may be indicative of a role for this enzyme in the preferential excision of lesions observed in such areas (Bohr et al., 1985) .
Numerous inhibitors of topoisomerase activity have been identified, affecting specifically both topoisomerase I (for example, camptothecin: Mattern et al., 1987; Hsiang et al., 1985 , Eng et al., 1988 and topoisomerase II (for example VP16 : Chen et al., 1984) . In this study, camptothecin and VP16 were employed in an attempt to modify the radiation sensitivity of a human tumour cell line to demonstrate a possible role for topoisomerases in the repair of ionising radiation-induced DNA damage. A previous study demonstrated a sensitisation of cells by novobiocin (Kelland & Steel, 1988) , reportedly an inhibitor of topoisomerase II, although Warters et al. (1989) found no sensitisation. Novobiocin has been shown to be a general inhibitor of oxidative metabolism (Downes et al., 1985) so that these experiments have not established unequivocally the involvement of topoisomerase in the repair process (Downes & Johnson, 1988) . A combination of the two agents was also used following a report that topoisomerases may be able to substitute for one another (Yanagida & Wang, 1987 (Steel & Peacock, 1989) Johnstone & McNerney (1985) . Briefly, combined cytosolic and nuclear extracts were prepared and incubated for 30 min at 37°C with supercoiled pBR322 plasmid DNA either in the absence, or presence, of varying concentrations of camptothecin. The reaction was stopped by the addition of stop solution containing SDS, the plasmid samples were then run on a 1 % agarose gel overnight and the activities of the camptothecin-treated extracts in relaxing the plasmid were estimated relative to that seen in untreated extract. Figure 2 shows the effects of a 50 #g ml-' concentration of VP16 on the radiosensitivity of RT1 12. Although this concentration was sufficient to kill 70% of unirradiated cells, it had no effects upon the shape of the survival curves, nor did a range of lower concentrations, from 5 to 25 ig ml-' (data not shown).
Camptothecin plus VP16 Figure 3 shows the effects of combining the exposures to the two drugs on the radiosensitivity of RT1 12. No difference was seen between the effects of exposure to camptothecin alone and a combined exposure (DER values of 1.09 and 1.33 for high and low dose rate irradiations respectively).
The effect of camptothecin on repair of SLD Figure 4 shows the results of split-dose experiments in which two doses of Gy were separated by increasing intervals of time from 1 to 4 h. Camptothecin, where appropriate, was present for 30 min before the first irradiation and for the subsequent 5 h. The results are expressed in terms of the recovery ratio, that is, the ratio of the surviving fraction measured at each time interval to that seen with no dose separation. In the absence of camptothecin the recovery ratio was 2.60 ± 0.37 and repair was complete within 3 h. However, when camptothecin was present between the doses there was a reduction in the recovery ratio to 1.78 ± 0.24. The effect of camptothecin on the activity of topoisomerase I Cellular extracts were prepared from RTl 12 and used to unwind supercoiled plasmid DNA in the presence of various concentrations of camptothecin. The drug inhibited the unwinding activity of the extracts such that 0. 87 fig ml' , the concentration used for the survival experiments, reduced activity to 30% of that seen in the untreated controls ( Figure   6 ).
Discussion
Numerous studies have been published reporting on the effects of inhibitors of topoisomerase on the repair of lesions induced by ultraviolet radiation. However, many of these have used novobiocin which has been shown to exert its effect by a general inhibition of oxdiative metabolism (Downes et al., 1985) ; a role for topoisomerase was, thus, not conclusively demonstrated by these experiments. Studies using specific inhibitors of topoisomerases, such as VP16, are fewer but again have concentrated on ultraviolet radiation. These have tended to show little or no effect of VP16, or mAMSA, on DNA repair processes in intact human cells (Wilkins, 1983; Downes et al., 1987; Snyder, 1987) . Similarly the murine L cell mutant tsAlS9 which has a temperature sensitive topoisomerase II (Colwill & Sheinin, 1983) has been shown to be repair-competent at the non-permissive temperature (Cleaver, 1972) .
Little, or no, information has been published on the effects of inhibitors of topoisomerases on sensitivity to ionising radiation. Here we report that camptothecin, but not VP16, significantly affected cell survival at non-toxic doses following both high and low dose-rate irradiation. If, and only if, these inhibitors are indeed specific for the respective enzymes, then this would tend to argue that topoisomerase I, but not topoisomerase II, is involved in the cellular recovery from ionising radiation-induced damage. No evidence was found that the two topoisomerases could substitute for one another in the recovery process; a combiantion of the two inhibitors had exactly the same effect as camptothecin alone, no additional kill being generated by the presence of VP16. Again assuming the specificity of camptothecin, it can be hypothesised that the enzymic activity of topoisomerase I is required in the resolution of some form(s) of DNA damage induced by ionising radiation and that trapping of the topoismerase I molecules on DNA by complex formation with camptothecin leads to the failure of repair and eventual fixation of that damage. The molecular basis for this effect remains obscure but the damage appears to be that which is resolved during the processes of low dose-rate sparing, sublethal damage repair and potentially lethal damage repair. That the concentration of camptothecin required to prevent cellular recovery lay in the range over which topoisomerase I activity is inhibited lends supporting evidence to the hypothesis that the drug is affecting survival through a topoisomerase-mediated mechanism.
The lack of involvement of topoisomerase II in the repair of damage induced by ionising radiation has also been proposed by Warters et al. (1989) who found that inhibiton of topoisomerase II (albeit using novobiocin) had no effect on the rate of double-strand break rejoining, or on cell killing following radiation. Similarly Collins & Johnson (1979) found no inhibition of repair of ionising radiation-induced DNA lesions by concentrations of novobiocin that significantly disrupted the repair of u.v.-irradiated DNA. Our results provide further evidence for this viewpoint and indicate that inhibitors of topoisomerase II are unlikely to prove of value as modifiers of the initial slope of the acute cell survival curve. It is apparent that the clinical radioresponsiveness of human tumours correlates with the steepness of this initial slope (Fertil & Malaise, 1981; Deacon et al., 1984) so that the modification of this slope by inhibitors of DNA repair in vitro could point to a possible therapeutic gain in vivo. Although VP16 does not appear to be a candidate for use as a radiosensitiser, camptothecin looks more promising in that it reduced survival at a dose of 2 Gy from 0.8 to 0.64. Indeed, camptothecin has been shown to have antitumorigenic activity (Gallo et al., 1971; Wani et al., 1986) and, in a selection of derivative compounds, the level of this activity has been shown to correlate with the degree of inhibition of topoismerase I (Jaxel et al., 1989) . It seems possible that a combination of high concentrations of camptothecin and gamma irradiation could prove to be particularly effective in generating an antitumorigenic effect in that we have shown a component of cell killing that is due to an interaction between the two agents. We are currently investigating this interaction and extending our studies to normal cell lines to determine whether there may be any therapeutic advantage in using this combination of antitumorigenic agents.
